Comparing total number of individuals enrolled and randomized vs completed study (completion of both surveys for control or both surveys and all of the sessions for intervention.)
| Group | Value | 95% CI |
|---|---|---|
| Usual Care | 39 | |
| HIEP Intervention | 25 |
Last reviewed · How we verify
Improving Health Insurance Experiences for Adolescent and Young Adult Cancer Patients
NA trial testing Health Insurance Education Program (HIEP) in Adolescent in 86 participants. Completed in 20 September 2022.
| Lead sponsor | University of Utah |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | health services research |
| Enrollment | 86 |
| Start date | 21 October 2020 |
| Primary completion | 20 September 2022 |
| Estimated completion | 20 September 2022 |
| Sites | 3 locations across United States |
University of Utah
Adults 18 to 40, any sex, with Adolescent or Young Adult. Patients with the condition only — healthy volunteers not accepted.
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Comparing total number of individuals enrolled and randomized vs completed study (completion of both surveys for control or both surveys and all of the sessions for intervention.)
| Group | Value | 95% CI |
|---|---|---|
| Usual Care | 39 | |
| HIEP Intervention | 25 |
Questions surrounding satisfaction with the HIEP. These will be asked at the post-assessment interview and will consist of participants responses surrounding satisfaction with the HIEP. We will report percentages of participants who did 1 or more session and reported satisfaction with the HIEP.
| Group | Value | 95% CI |
|---|---|---|
| HIEP Intervention | 10 | |
| Usual Care | 0 |
Validated Patient Satisfaction with Navigator Interpersonal Relationship (PSN-I) measure at post assessment survey. This score ranges from 0-45 with higher scores indicating higher satisfaction. We will report the mean and standard deviation.
| Group | Value | 95% CI |
|---|---|---|
| HIEP Intervention | 30.84 | ± 16.15 |
| Usual Care | 30.32 | ± 12.95 |
Differences between Health Insurance Literacy Measure (HILM) reported at the intro baseline and exit post-assessment survey. For this study, the last two sections (3\&4) of the HILM were used. Scores range from 9-36 with lower scores indicate lower health insurance literacy and worse outcomes. Differences will be examined by age group and by treatment arm. We report mean and standard deviation. Please note that not all participants, filled out all necessary questions at both timepoints to be assessed.
| Group | Value | 95% CI |
|---|---|---|
| HIEP Intervention | 5.39 | ± 6.44 |
| Usual Care | 2.30 | ± 6.06 |
| Combined | 3.84 | ± 6.40 |
Questions surrounding familiarity with the ACA reported at the baseline and post-assessment survey. Values range from 0 to 28 with higher scores indicating better familiarity with ACA concepts. We will report the mean and standard deviation of the difference in response scores between baseline and post assessment for the control and intervention. Please note that not all participants, filled out all necessary questions at both timepoints to be assessed.
| Group | Value | 95% CI |
|---|---|---|
| HIEP Intervention | 5.84 | ± 6.30 |
| Usual Care | 2.03 | ± 4.89 |
| Combined | 3.93 | ± 5.92 |
Differences between COmprehensive Score for financial Toxicity (COST) reported at the baseline and post-assessment survey. Values range from 0 to 44 where lower COST scores indicate worse financial toxicity. Differences will be examined by age group and by treatment arm. We will report mean and standard deviation. Please note that not all participants, filled out all necessary questions at both timepoints to be assessed.
| Group | Value | 95% CI |
|---|---|---|
| HIEP Intervention | 3.70 | ± 9.59 |
| Usual Care | 2.89 | ± 9.44 |
| Combined | 3.32 | ± 9.26 |
| Group | Value | 95% CI |
|---|---|---|
| HIEP Intervention | 3.08 | ± 8.45 |
| Usual Care | 0.741 | ± 6.42 |
| Combined | 1.87 | ± 7.48 |
| Group | Value | 95% CI |
|---|---|---|
| HIEP Intervention | 3.25 | ± 8.65 |
| Usual Care | 1.28 | ± 7.20 |
| Combined | 2.25 | ± 7.95 |
This is a test of an existing health insurance education program (HIEP) in adolescent and young adult (AYA) individuals (aged 18-39) diagnosed with cancer. The study will evaluate whether the HIEP delivered by patient navigators improves participants' health insurance and cost-related literacy compared to usual navigation care, which does not include education on insurance and medical costs. The study team hypothesizes that: The HIEP will improve participants' health insurance and cost-related literacy compared to usual navigation care. Specifically, that participants in the intervention arm will report greater 1) health insurance and cost literacy, including confidence with provider communication about costs, 2) familiarity with ACA policies, and 3) improvement in financial distress related to medical costs. Participants will fill out a survey upon enrollment and a follow up survey 3 months after meeting with a patient navigator where they may or may not receive the HIEP.
6 peer-reviewed publications reference this trial (live from Europe PMC):
Verify or expand the search:
Trials testing the same drug.
Currently open trials in the same condition.
Trials by the same sponsor.
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04448678.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing